WO2013012302A2 - Elaboration d'un sirop anti-inflammatoire/anti-œdemateux naturel a base d'extraits aqueux de plantes originaires du sud-est du maroc - Google Patents
Elaboration d'un sirop anti-inflammatoire/anti-œdemateux naturel a base d'extraits aqueux de plantes originaires du sud-est du maroc Download PDFInfo
- Publication number
- WO2013012302A2 WO2013012302A2 PCT/MA2012/000012 MA2012000012W WO2013012302A2 WO 2013012302 A2 WO2013012302 A2 WO 2013012302A2 MA 2012000012 W MA2012000012 W MA 2012000012W WO 2013012302 A2 WO2013012302 A2 WO 2013012302A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- use according
- syrup
- macerate
- inflammatory
- inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Definitions
- This invention relates to the design and development of improved traditional phytomedicine based on five medicinal plants from South-East Morocco, selected from ethnopharmacological surveys.
- anti-inflammatory steroids also called AIS
- NSAIDs nonsteroidal anti-inflammatory drugs
- AIS are derivatives of natural corticosteroid hormones manufactured by the
- corticosteroids have an anti-oedematous action, and most importantly, a general anti-inflammatory action by preventing the release from the vessels of cells responsible for triggering inflammation and to reduce the influx. They are very powerful, widely used in stomatology, ENT and rheumatology. They have the disadvantages of corticosteroids (aggressiveness vis-à-vis the stomach, thinning
- the present invention relates to the field of health and particularly to that of the improved traditional phthalomedicine or dietary supplement. This invention brings an originality to the existing in terms of inflammation by the development of a phthtomedicine with a non-steroidal anti-inflammatory profile 100% natural.
- Herbal medicine offers many plants with anti-inflammatory properties, whose safety is recognized for the most part, and to use in their natural state in the form of infusion or decoction for some. For others, laboratories offer them in different forms: powder, extracts, mother tinctures (Cassis, Queen of the Near, Willow, Turmeric ).
- Rosmarinus officinalis is known as an antioxidant and hepatoprotective in rats [3].
- the hydroalcoholic extract of this species has an anti-ulcerogenic capacity by decreasing the index of indomethacin-induced ulcer [4].
- Other studies have shown that the methanolic extract of R. officinalis is known for its antioxidant and antibacterial effect [6].
- the essential oil of the species Artemisia herba-alba has been studied phytochemically and biologically. It has been shown that the essential oil of white wormwood is endowed with a set of activities such as anti-oxidant, anti-venous, antifungal, anti-bacterial, anti-spasmodic and hypoglycemic activities [7].
- the essential oil of Mentha pulegium has also been studied phytochemically, and 28 chemical compounds have been identified by GC-FID and GC-MS [8].
- the essential oil of Mentha suaveolens has also been shown to be more than 50% inhibitory of acetylcholinesterase [9]. - Detailed description of the invention
- This syrup is the result of a synergy of effects of five plant species (Rosmarinus officinalis L., Phoenix dactylifera L., Artemisict herba-alba Asso, Menthq pulegium L. and Mentha suaveolens Ehrh.), Selected for their inflammatory diseases in the traditional therapeutic arsenal of the Rissani-Errachidia area (South-East Morocco).
- the five species were harvested in October 2010 in the region of Rissani-ER-Rachidia, identified and herborized at the herbarium of the National Institute of Medicinal and Aromatic Plants (INPMA) of Taounate: exsiccata No. INP216 ( R. officinalis), ⁇ 215 (P. dactylifera), ⁇ ⁇ 218 (A. herba-alba), ⁇ 221 (M. pulegium) and ⁇ 220 (M. suaveolens).
- INP216 R. officinalis
- ⁇ 215 P. dactylifera
- ⁇ ⁇ 218 A. herba-alba
- ⁇ 221 M. pulegium
- ⁇ 220 M. suaveolens
- Example 2 Aqueous extraction of the five species The five plants were dried and crushed. They were macerated in equal parts in distilled water for 3 hours with continuous stirring. Then, the macerate was filtered with Whatman No. 1 filter paper. The resulting filtrate was rotavaporized (B ⁇ CHI Rotavapor R-205), and a dry residue was recovered with a yield of 31.92%.
- Flavonoids cyanidine reaction
- tannins ferrric chloride test
- coumarins ammonia test
- anthraquinones and anfhocyanates potassium hydroxide test
- saponins fluorescence index
- steroidal sapogenins sulfuric acid test
- cardiac glycosides sulfuric acid test
- free quinones sodium hydroxide test
- Mucilages absolute alcohol test
- oses and holosides test with sulfuric acid and thymol
- Macerate contains a number of chemical families such as flavonoids, tannins, mucilages, anthraquinones, coumarins, oses and holosides, generally known by their anti-inflammatory effect (Table 1).
- Example 4 Spectrophotometric determination of flavonoids compounds known by their anti-inflammatory power
- the level of flavonoids was evaluated by spectrophotometry by measuring the absorbance of quercetin in the macerate of the plants studied. The more this species is rich in flavonoids, the higher the optical density of the macerate is important.
- the spectrophotometer is previously calibrated on the absorption wavelength of quercetin (430 nm).
- the syrup made from the plant macerate is rich in flavonoids (16.934 mg quercetin equivalent / g dry extract) ( Figure 1).
- the procedure for evaluating the tannin content consists in carrying out macerations at 10%, repeated 3 times in acetone at 70%; then the macerates were filtered and evaporated under pressure (B ⁇ CHI Rotavapor R-205). Finally, the dry residue is recovered with a yield of 21.68%.
- mice were randomized into control groups and treated and divided into 5 groups of 1 to 9 animals each.
- Group 1 animals were administered with normal saline (0.9% NaCl).
- Groups 2, 3 and 4 animals were administered with the aqueous macerate of the five species studied at doses of 200, 1000 and 5000 mg / kg, bw Animals in group 5 were administered with indomethacin at a dose of 10 mg / kg, pc All treatments were administered orally between 13:00 120 until 14:00 h.
- the macerate administered orally at different doses (0.2, 1 and 5 g / kg, p.c.) has a significant anti-inflammatory / anti-edematous effect (Table 2).
- n 9, *: p ⁇ 0.05 at 6 o'clock.
- Treaty 1 1 11.33 ⁇ 16.16 38.69 ⁇ 0.51 12.43 ⁇ 0.22 3.40 ⁇ 0.01 3.02 ⁇ 0.03
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MA34033 | 2011-07-15 | ||
| MA34033A MA33970B1 (ar) | 2011-07-15 | 2011-07-15 | تطوير شراب مضاد الالتهاب طبيعي من مستخلص النبتات المائية المستندة من جنوب شرق المغرب |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2013012302A2 true WO2013012302A2 (fr) | 2013-01-24 |
| WO2013012302A3 WO2013012302A3 (fr) | 2014-05-08 |
Family
ID=47558648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/MA2012/000012 Ceased WO2013012302A2 (fr) | 2011-07-15 | 2012-06-26 | Elaboration d'un sirop anti-inflammatoire/anti-œdemateux naturel a base d'extraits aqueux de plantes originaires du sud-est du maroc |
Country Status (2)
| Country | Link |
|---|---|
| MA (1) | MA33970B1 (ar) |
| WO (1) | WO2013012302A2 (ar) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10004778B1 (en) | 2017-05-25 | 2018-06-26 | Sultan Qaboos University | Method of making an Ajwa date-based treatment for snake envenomation |
| WO2020074132A1 (fr) * | 2018-10-11 | 2020-04-16 | Mytamar Gmbh | Utilisation cosmétique d'un extrait de polyphénols issu des fruits du palmier dattier phoenix dactylifera |
-
2011
- 2011-07-15 MA MA34033A patent/MA33970B1/ar unknown
-
2012
- 2012-06-26 WO PCT/MA2012/000012 patent/WO2013012302A2/fr not_active Ceased
Non-Patent Citations (3)
| Title |
|---|
| HEILWEIL M F ET AL: "TESTING ELECTROMAGNETIC SWITCHING DEVICES", IBM TECHNICAL DISCLOSURE BULLETIN,, vol. 9, no. 4, 1 septembre 1966 (1966-09-01), page 367, XP001608322, * |
| LATIFA EL MANSOURI ET AL: "Phytochemical screening and anti-inflammatory property of one recipe from moroccan traditional medicine", INTERNATIONAL JOURNAL OF PHYTOPHARMACOLOGY,, vol. 5, no. 2, 1 janvier 2014 (2014-01-01) , pages 76-84, XP009176893, * |
| LATIFA EL MANSOURI ET AL: "Socioeconomic interest and valorization of medicinal plants from the Rissani oasis (SE of Morocco)[Interés socioeconómico y valorización de plantas medicinales del oasis de Rissani (SE de Marruecos)]", BOLETÍN LATINOAMERICANO Y DEL CARIBE DE PLANTAS MEDICINALES Y AROMÁTICAS, vol. 10, no. 1, 1 janvier 2011 (2011-01-01), pages 30-45, XP55107858, ISSN: 0717-7917 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10004778B1 (en) | 2017-05-25 | 2018-06-26 | Sultan Qaboos University | Method of making an Ajwa date-based treatment for snake envenomation |
| WO2020074132A1 (fr) * | 2018-10-11 | 2020-04-16 | Mytamar Gmbh | Utilisation cosmétique d'un extrait de polyphénols issu des fruits du palmier dattier phoenix dactylifera |
Also Published As
| Publication number | Publication date |
|---|---|
| MA33970B1 (ar) | 2013-02-01 |
| WO2013012302A3 (fr) | 2014-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8206753B2 (en) | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes | |
| US7579023B2 (en) | Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals | |
| García-Barrantes et al. | Anti-ulcerogenic properties of Quassia amara L.(Simaroubaceae) standardized extracts in rodent models | |
| KR101384410B1 (ko) | 매실나무 추출물의 조성물 제조에서의 응용 | |
| US12514896B2 (en) | Pharmaceutical composition on the basis of stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo | |
| Tchoumba Tchoumi et al. | Antimicrobial and antidiarrhoeal activities of aqueous and methanolic extracts of Mangifera indica Linn stem bark (Anarcadiaceae) in Wistar rats: LMT Tchoumi et al. | |
| Evenamede et al. | Comparative study of the toxicity of hydroethanolic extracts of the root and stem barks of Cassia sieberiana DC on Wistar rats. | |
| KR101009904B1 (ko) | 천연 식물 추출물을 포함하는 항염 조성물 | |
| Ingale et al. | Exploring the use of herbal medicines in the context of dermatokinetic research | |
| Saroj et al. | Butea monosperma (Palash)-its ethnobotanical knowledge, phytochemical studies, Pharmacological aspects and future prospects | |
| Yondo et al. | Nematicidal efficacy of methanol/methylene chloride extract of Rauwolfia vomitoria (Apocynacae) on Heligmosomoides bakeri (Nematoda, Heligmosomatidae) parasite of the white mouse (Mus musculus) | |
| Liyanaarachchie et al. | In vitro antidiabetic and in vivo hypoglycaemic activities and toxicity of Canarium zeylanicum bark extracts | |
| Silalahi | Morinda citrifolia: Bioactivity and utilization as traditional medicine and food for the community | |
| JP2009518429A (ja) | 代謝症候群および糖尿病の治療のための抗炎症植物産物 | |
| YAdAv et al. | Characterization of the Bryophyllum pinnatum leaf's Active Component and It's Antidiarrheal Potential. | |
| FR2793141A1 (fr) | Extrait de bourgeons de peuplier et son association avec le squalane pour son utilisation en tant que medicament anti-inflammatoire et dans un procede de traitement cosmetique | |
| Al-Zeiny et al. | Evaluation Effects of Methanolic Extract of Date and Leaves Oily and Alcoholic Extract of Phoenix Dactylifera for Treated Diarrheal in Rats | |
| RATHOUR et al. | Review on Syzygium cumini Linn: A promising ethnopharmacological plant. | |
| Sorucu et al. | Investigation of the Gastroprotective Activity of Propolis Extracted in Different Solvents | |
| Ifegwu et al. | Combined effect of ethanolic leaf extracts of Carica papayaand Newbouldia laevison the histology of testes of Alloxan-induced diabetic rats | |
| KR102001024B1 (ko) | 프로폴리스를 포함하는, 위염 및 헬리코박터 파일로리 억제를 위한 조성물 | |
| Boukongo et al. | Evaluation of the Effect of the Aqueous Extract of the Recipe of the Leaves of O. Grastissium and the Steam Bark of T. Superba on Acetic Acid-Induced Spasms in Wistar Rats | |
| KR20250010260A (ko) | 동물 피부질환 개선용 약학적 조성물 | |
| Loumpangou et al. | Androgenic Effect and Phytochimie of the Bark of Trunk of Buchholzia coriacea Engl.(Capparidaceae) | |
| Hakami | Influence of Oral Intake of Rose Water on the Kidney of Mouse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 12814401 Country of ref document: EP Kind code of ref document: A2 |